AURA

Aura Biosciences Stock Analysis

AI Rating

Fair
  • Quality4/10
  • Growth↓ 0/10
  • Value↑ 5/10
Aura Biosciences sales and earnings growth
AURA Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -12.14%
  • FCF Y/Y↓ -19.17%
Aura Biosciences gross and profit margin trends
AURA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -54.67%
Aura Biosciences net debt vs free cash flow
AURA Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Aura Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗